Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.0500
+0.0085 (20.48%)
At close: Feb 12, 2026
Nymox Pharmaceutical Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
5.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 5.00K | -111.00K | -95.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Clearside Biomedical | 3.33M |
| Orgenesis | 899.00K |
| Vaccinex | 601.00K |
| GPL Holdings | 376.54K |
| AXIM Biotechnologies | 92.90K |
| Enzolytics | 46.59K |
| Enzon Pharmaceuticals | 26.00K |
Nymox Pharmaceutical News
- 1 year ago - Nymox Announces Dismissal of Delaware Action Against Ascella - GlobeNewsWire
- 1 year ago - NYMOX Announces Trading Resumed and New Listing on OTCQB Market - GlobeNewsWire
- 1 year ago - Nymox Announces Filing of Annual Report - GlobeNewsWire
- 1 year ago - Nymox Annual Report - GlobeNewsWire
- 1 year ago - Nymox Required to Resubmit Application to DKMA - GlobeNewsWire
- 2 years ago - Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages - GlobeNewsWire
- 2 years ago - Nymox December 27 Message to Shareholders - GlobeNewsWire
- 2 years ago - Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others - GlobeNewsWire